The top news stories from Latin America

Provided by AGP

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on May 13, 2026

National Coalition for Homeless Veterans 2026 Annual Conference to Be Held in Washington, DC May 27-29
AMPP Brings Industry Voice to Capitol Hill as Infrastructure Policy Focus Shifts to Long-Term Performance
International Polo Tour® Makes Historic Return in Ecuador with the IPT BUGGATTI World Cup Invitational
Healthcare AI Startup ASTRID Adds Spanish Across Medical, Dental, and Veterinary AI Agents
A Tennessee Titans Team Physician Sees Rising Trend of Adults Choosing Regenerative Alternatives Before Knee Replacement
Aurelio De La Vega Centennial Celebration Concert on Tuesday May 19 in New York City
Adsterra Explica Su Sistema Antifraude y Antimalware para Proteger a Anunciantes y Editores
New CCW Digital Analyst Report Positions BPOs as Strategic Accelerators for CX
AuctionWorks Announces Public UCC Sale of Membership Interests Tied to Puerto Rico Real Estate
XS.com Reconhecida como “Melhor Corretora de CFDs” em Evento da Rankia no Peru
XS.com es reconocido como el “Mejor Bróker de CFD” en el evento Rankia en Perú
Century Therapeutics Reports First Quarter Financial Results and Business Updates 
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial
Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus
Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药
Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗,已為首位患者完成給藥
Pyxis Oncology to Participate in Upcoming Investor Conferences
Altimmune Announces First Quarter 2026 Financial Results and Business Update
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions

Share us

on your social networks:

Sign up for:

The Latin American Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.